AcroImmune Biopharma was founded by Professor Yang Liu, an internationally renowned immunologist, Fellow of the American Association for the Advancement of Science (AAAS), and founder of OncoImmune Inc. The company established AcroImmune BioTech. Co., Ltd.(SuZhou) in the Suzhou Industrial Park in 2017 and AcroImmune BioTech. Co., Ltd.(GuangZhou) on Guangzhou International Bio Island in 2018.

OncoC4 is dedicated to developing innovative immunotherapeutic drugs, with a focus on the treatment of malignant tumors and inflammatory diseases. The company boasts a robust pipeline of novel drugs, including several Best-in-Class and First-in-Class candidates. These innovative products are the result of cutting-edge research and development aimed at addressing significant unmet medical needs.